ZAG expression in breast cancer has been documented and is considered as a potential biomarker for breast carcinoma [50, 76–79] because its expression is detected exclusively in patients with ductal carcinoma when compared to the normal breast tissue of healthy women. The gene discussed is AZGP1; the disease is breast ductal adenocarcinoma.